Figure 3.
Primary (Modified Vesikari Scale score) and secondary outcomes (emergency department revisits, diarrhea duration and number of episodes) analyzed separately for each of the probiotic treatment groups. Treatment effect of each probiotic product compared to placebo is estimated with 95% Bonferroni CIs. Abbreviations: CI, confidence interval; LGG, Lactobacillus GG.

Primary (Modified Vesikari Scale score) and secondary outcomes (emergency department revisits, diarrhea duration and number of episodes) analyzed separately for each of the probiotic treatment groups. Treatment effect of each probiotic product compared to placebo is estimated with 95% Bonferroni CIs. Abbreviations: CI, confidence interval; LGG, Lactobacillus GG.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close